PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Rheumatology and Immunology Center, China Medical University Hospital, Taichung, Taiwan.\', \'College of Medicine, China Medical University, Taichung, Taiwan.\', \'Translational Medicine Laboratory, China Medical University Hospital, Taichung, Taiwan.\', \'Rheumatic Diseases Research Center, China Medical University Hospital, Taichung, Taiwan.\', \'Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.\', \'Department of Laboratory Medicine, China Medical University Hospital, Taichung, Taiwan.\', \'Ph.D. Program in Translational Medicine and Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.719544
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34367188
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still\'s Disease From COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all